 "Top headlines: PM lays Noida airport foundation; Covaxin's efficacy updated")
Bharat Biotech updates Covaxin efficacy to 65.2% against Delta variant
Bharat Biotech has updated the efficacy of Covaxin to 65.2% against the Delta variant in - Effectiveness Study on Delta Variant - Lancet Infectious Diseases, published on Nov 23 2021.
"Bharat Biotech commends the investigators from the All India Institute of Medical Sciences (AIIMS) on the BBV152 study published in Lancet Infectious Diseases. These results provide evidence for effectiveness for Covaxin in real life settings," Bharat Biotech said. Read more
ITC starts clinical trials for nasal spray to prevent Covid-19 infection
Diversified conglomerate, ITC, is developing a nasal spray for Covid-19 prevention for which it has initiated clinical trials.
An ITC spokesperson confirmed the development but said, “We are unable to share more details at the current moment as the clinical trials are underway.” Read more
PM Modi says Jewar airport will be 'logistics gateway for north India'
Taking a swipe at previous governments, Prime Minister Narendra Modi on Thursday said Uttar Pradesh was kept in deprivation and darkness earlier but it is now getting what it always deserved and is making its mark internationally under a "double-engine" BJP rule.
After laying the foundation stone for the Noida International Airport at Jewar in Uttar Pradesh, which would one of the largest aerodromes in Asia, Modi highlighted the development activities in the poll-bound state and said the new airport will help the state become an export-centre whereby even MSMEs will have easier access to overseas markets. Read more
BlackRock, Canada Pension bought more Paytm stock after weak market debut
Several of the biggest investors in Paytm’s record-breaking initial public offering added to their stakes in the Indian fintech giant after shares plunged by as much as 41%, according to people familiar with the matter.
BlackRock Inc. and Canada Pension Plan Investment Board were among so-called anchor investors in the IPO that bought more Paytm shares on Tuesday and Wednesday, the people said, asking not to be identified discussing private information. Read more
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%